Diabetes and ADHD drugs to be tested on Alzheimer's patients in new study
New study tests Diabetes and ADHD drugs on Alzheimer's patients
60 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 60 separate news trends connected to Diabetes, spanning June 20, 2026 through October 22, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 455 article observations and 437 source signals, led by Health, Business, Technology coverage. Use it to compare how individual events emerged, spread and changed over time.
New study tests Diabetes and ADHD drugs on Alzheimer's patients
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
A strange sugar in red meat linked to a higher diabetes risk
Half of early‑onset type 2 diabetes patients entered remission after a low‑energy diet and structured exercise, per a new study.
13 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
People who rely on GLP-1s for weight loss face a daunting prospect: regaining weight after stopping treatment.
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Thousands of people may live longer thanks to a common diabetes tool.
Continuous glucose monitors may protect kidneys from early damage caused by diabetes.
Consuming olive oil before carbs may alter the post-meal blood glucose response.
14 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Doctors warn of potential fertility impact from GLP-1 drugs, sparking hope and concern among couples.
15M Americans take GLP-1 drugs, with some seeking cheaper alternatives due to high costs.
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Seven days of fasting triggers drastic changes in the human body
Rare vision risk linked to GLP-1 drugs sparks concern
Eating alone may raise blood sugar, new study suggests.
Rising risk of heart failure, kidney disease, or death for those with type 2 diabetes
7 news sources are covering this Entertainment story right now — Archynetys is tracking how fast it spreads.
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
13 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Roche's obesity drug shows promise in mid-stage trial with significant weight loss and improved blood sugar control.
Massachusetts man shares sudden blindness journey after taking GLP-1, sparking lawsuits and safety concerns.
The vivid dream stage of REM sleep is linked to a lower risk of 83 diseases, including diabetes, according to newly published sleep research.
New nutritionist guidance flips the script, showing coffee can boost longevity when brewed right
GLP-1s linked to nutritional deficiencies in nearly 1 in 6 children, raising questions about parental conversations.
Common class of drugs linked to lower dementia risk
Frequent night‑time bathroom trips are prompting doctors to flag hidden health concerns, turning a common annoyance into a potential warning sign.
Ozempic may boost mental health, sparking debate over GLP‑1 drugs' psychological impact
Four articles published on August 31, 2026, have people with diabetes questioning which fruit is better for their blood sugar.
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
The FDA's approval of a new use for the diabetes drug Mounjaro is trending, with five outlets reporting on the expanded indication.
A 2026 Queen Mary study shows type 2 diabetes shortens men’s lives by a decade while raising women’s mental‑health risk.
New research suggests that avoiding certain health risks can help maintain cognitive function as we age.
A cholesterol pill may cut dementia risk by 15% for diabetics, sparking debate over a new use for statins.
The FDA's approval of Lilly's Mounjaro for cardiovascular risk reduction is a major win for the company and a potential game-changer for diabetes patients.
A rise in liver disease among younger adults and those with diabetes is sparking concern among health professionals.
The FDA's approval of a wearable device to monitor glucose and ketones is reshaping diabetes management.
Eli Lilly's new weight-loss pill Foundayo is now available in the U.K., marking a significant milestone in the pharmaceutical industry.
A new probiotic can sense high blood sugar and release a diabetes drug on demand, potentially revolutionizing treatment.
A new treatment could revolutionize weight loss and diabetes management by targeting fat while preserving muscle.
New scientific findings suggest that three minutes of sprinting can alter blood chemistry and stimulate protective proteins in ways longer sessions cannot.
Scientists have identified a molecule that could revolutionize muscle strengthening and diabetes treatment.
A Chinese team is racing to bring a 'smart' probiotic for diabetes to the US market.
A 3-minute sprinting routine may offer health benefits comparable to an hour of moderate exercise.
Diabetes-friendly breakfast options are trending as more people seek to manage blood sugar levels through diet.
Experts are advising changes to evening routines to reduce stroke risk.
A genetic study of one million people identifies the FNIP1 variant as a key factor in maintaining low body fat and metabolic health.
Smartwatches are evolving into medical devices, but healthcare systems are not yet prepared.
Millions taking common medication face new questions regarding the potential acceleration of Alzheimer’s disease progression.
Bleeding gums may signal risks beyond oral health, according to recent medical insights.
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Recent coverage examines the functionality and accuracy of blood pressure tracking on the Apple Watch and other wearable health devices.
Medical professionals and health outlets are highlighting dietary choices and daily habits to protect kidney function and manage chronic disease.
New research suggests that weekly strength training can lower the risk of heart disease, diabetes, and early death.
Researchers and doctors are exploring the broader implications of GLP-1 weight loss drugs as their use becomes more widespread.
Intermittent fasting is gaining traction as a potential alternative to calorie counting for weight loss.
Recent studies suggest coffee may have hidden benefits for gut health and aging.